11:51 AM EST - Sirona Biochem Corp. : Reports that In Vitro studies completed on compounds developed by our scientists at TFChem have shown a strong potential for anti-cellulite activity. The data showed evidence for both the ability to reduce existing cellulite and to prevent the formation of new cellulite. The mechanism of action is technically complex involving a pro-lipolytic effect, a decrease of the adipocyte size and an anti-inflammatory effect. Sirona Biochem Corp.
shares V.SBM are trading up $0.005 at $0.21.
